Award

Delivery Order #SPE2DR26F7QHZ

Delivery Order for Atomoxetine Capsules to AmerisourceBergen

Buyer

Defense Logistics Agency

Award Amount

$826.92

Ceiling

$826.92

Awarded

March 11, 2026

Period of Performance

Mar 11, 2026 – Mar 12, 2026

Identifier

SPE2DR26F7QHZ

NAICS

325411

This award is a delivery order contract issued under an existing indefinite delivery vehicle (IDV) held by AmerisourceBergen Drug Corporation, a leading pharmaceutical wholesaler specializing in drug distribution services. The procurement involves the supply of Atomoxetine HCL 40 mg capsules, a specific pharmaceutical product, reflecting a focused medication delivery to support healthcare needs. The contract is significant as it ensures the availability of essential medication within the public sector, particularly for federal healthcare facilities, contributing to the continuous and reliable pharmaceutical supply chain. The scope of work is narrowly tailored to the delivery of a defined quantity of Atomoxetine capsules over a very short, specified period, highlighting a targeted and timely pharmaceutical need. Awarded through a delivery order mechanism under a broader IDV, this procurement supports and complements the long-term agreement, which enhances drug distribution efficiency. The contract’s performance is scheduled for a brief timeframe in early 2026, emphasizing prompt fulfillment and delivery. No competitive bidding details were provided, consistent with the use of a task order under an established contract vehicle.

Description

4571110535!ATOMOXETINE HCL 40 MG CAPSULE 30S

View original record